Literature DB >> 14508521

Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization.

Puneeth Iyengar1, Terry P Combs, Shalin J Shah, Valérie Gouon-Evans, Jeffrey W Pollard, Chris Albanese, Louise Flanagan, Martin P Tenniswood, Chandan Guha, Michael P Lisanti, Richard G Pestell, Philipp E Scherer.   

Abstract

Mammary epithelial cells are embedded in a unique extracellular environment to which adipocytes and other stromal cells contribute. Mammary epithelial cells are critically dependent on this milieu for survival. However, it remains unknown which adipocyte-secreted factors are required for the survival of the mammary epithelia and what role these adipokines play in the process of ductal carcinoma tumorigenesis. Here, we take a systematic molecular approach to investigate the multiple ways adipocytes and adipokines can uniquely influence the characteristics and phenotypic behavior of malignant breast ductal epithelial cells. Microarray analysis and luciferase reporter assays indicate that adipokines specifically induce several transcriptional programs involved in promoting tumorigenesis, including increased cell proliferation (IGF2, FOS, JUN, cyclin D1), invasive potential (MMP1, ATF3), survival (A20, NFkappaB), and angiogenesis. One of the key changes in the transformed ductal epithelial cells associated with the cell cycle involves the induction of NFkappaB (five-fold) and cyclin D1 (three-fold). We show that by regulating the transcription of these molecules, the synergistic activity of adipocyte-derived factors can potentiate MCF-7 cell proliferation. Furthermore, compared to other stromal cell-secreted factors, the full complement of adipokines shows an unparalleled ability to promote increased cell motility, migration, and the capacity for angiogenesis. Adipocyte-secreted factors can affect tumorigenesis by increasing the stabilization of pro-oncogenic factors such as beta-catenin and CDK6 as a result of a reduction in the gene expression of their inhibitors (i.e. p18). An in vivo coinjection system using 3T3-L1 adipocytes and SUM159PT cells effectively recapitulates the host-tumor interactions in primary tumors. Type VI collagen, a soluble extracellular matrix protein abundantly expressed in adipocytes, is further upregulated in adipocytes during tumorigenesis. It promotes GSK3beta phosphorylation, beta-catenin stabilization, and increased beta-catenin activity in breast cancer cells and may critically contribute towards tumorigenesis when not counterbalanced by other factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14508521     DOI: 10.1038/sj.onc.1206737

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  130 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

2.  Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes.

Authors:  Shira Landskroner-Eiger; Jiyoung Park; Davelene Israel; Jeffrey W Pollard; Philipp E Scherer
Journal:  Dev Biol       Date:  2010-06-19       Impact factor: 3.582

3.  Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells.

Authors:  Qinglin Li; Jixiang Xia; Yuan Yao; Da-Wei Gong; Hongfei Shi; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2013-09-04       Impact factor: 4.872

4.  Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.

Authors:  Terence M Williams; Federica Sotgia; Hyangkyu Lee; Ghada Hassan; Dolores Di Vizio; Gloria Bonuccelli; Franco Capozza; Isabelle Mercier; Hallgeir Rui; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 5.  Studying Adipose Tissue in the Breast Tumor Microenvironment In Vitro: Progress and Opportunities.

Authors:  David Mertz; Jason Sentosa; Gary Luker; Shuichi Takayama
Journal:  Tissue Eng Regen Med       Date:  2020-09-16       Impact factor: 4.169

Review 6.  Three-dimensional context regulation of metastasis.

Authors:  Janine T Erler; Valerie M Weaver
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

7.  Adipocytes impair leukemia treatment in mice.

Authors:  James W Behan; Jason P Yun; Marina P Proektor; Ehsan A Ehsanipour; Anna Arutyunyan; Ara S Moses; Vassilios I Avramis; Stan G Louie; Anna Butturini; Nora Heisterkamp; Steven D Mittelman
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 8.  Obesity and cancer--mechanisms underlying tumour progression and recurrence.

Authors:  Jiyoung Park; Thomas S Morley; Min Kim; Deborah J Clegg; Philipp E Scherer
Journal:  Nat Rev Endocrinol       Date:  2014-06-17       Impact factor: 43.330

9.  Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.

Authors:  Shira Landskroner-Eiger; Binzhi Qian; Eric S Muise; Andrea R Nawrocki; Joel P Berger; Eugene J Fine; Wade Koba; Yingfeng Deng; Jeffrey W Pollard; Philipp E Scherer
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

10.  Non-Linear Optical Imaging of Obesity-Related Health Risks: Review.

Authors:  Thuc T Le; Ji-Xin Cheng
Journal:  J Innov Opt Health Sci       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.